From the Department of Orthopaedics, Stony Brook Medicine, Stony Brook, NY.
J Am Acad Orthop Surg Glob Res Rev. 2022 Jul 6;6(7). doi: 10.5435/JAAOSGlobal-D-22-00038. eCollection 2022 Jul 1.
Biopsy site infection in the setting of osteosarcoma is a potentially devastating complication. We present the case of a 16-year-old adolescent girl with a distal femur osteosarcoma who developed an open biopsy site ulceration and infection after initiation of neoadjuvant chemotherapy. This was treated with careful local excision of the ulcerated biopsy site and systemic antibiotic therapy throughout the duration of her chemotherapy course. She subsequently underwent wide resection of the tumor en bloc with a generous ellipse around the biopsy scar and reconstruction with cemented knee megaprosthesis. No recurrence of either infection or malignancy was observed. This case represents the successful treatment of a biopsy site ulceration and infection in a patient with osteosarcoma and may merit adoption in future instances of this complication.
骨肉瘤患者活检部位感染是一种潜在的破坏性并发症。我们报告了一例 16 岁的青少年女性患者,她患有股骨远端骨肉瘤,在开始新辅助化疗后出现开放性活检部位溃疡和感染。经过仔细切除溃疡活检部位,并在整个化疗过程中全身应用抗生素治疗,该患者得到了治疗。随后,患者接受了广泛切除肿瘤,并在活检瘢痕周围用水泥固定的膝关节假体进行重建。患者既未出现感染复发,也未出现恶性肿瘤复发。本病例成功治疗了骨肉瘤患者的活检部位溃疡和感染,可能值得在未来该并发症的治疗中采用。